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Concentrations of Mycobacterium avium-M. intracellulare ranging from 10-1 to 163 CFU/ml were added to
blood, placed in Isolator tubes, and held at room temperature for intervals ranging from 4 h to 56 days before
being processed (centrifugation and culture on Middlebrook 7H10 agar). At all concentrations tested, M.
avium-M. intracellulare was recovered after hold times ranging from 4 h to 7 days; the number of final CFU
actually increased progressively for hold times of 8 h or more. Hold times of up to 7 days did not increase the
time from processing to the first appearance of visible colonies. At an inoculum of 102 CFU/ml, M. avium-M.
intracellulare was recovered from Isolator tubes processed 56 days after inoculation. Two Isolator blood
cultures were drawn from a patient with AIDS; M. avium-M. intracellulare was recovered from the sample
processed immediately and from the sample processed after a hold time of 7 days. Since M. avium-M.
intracelulare survives for prolonged periods in Isolator tubes, blood cultures may be collected in outpatient
settings or in hospitals without mycobacterial culture facilities and shipped to reference laboratories for
processing without loss of viability.
Disseminated infection with organisms of the Mycobacte-
rium avium complex (MAC) occurs in 30 to 50% of patients
with AIDS in the United States, usually among patients with
CD4 counts of less than 100/mm3 (7, 8). Disseminated
infection with MAC may produce disabling symptoms, in-
cluding fever, malaise, weight loss, and diarrhea (7). Care-
fully conducted analytical epidemiologic studies have dem-
onstrated that disseminated MAC shortens survival by 5 to 7
months among patients with AIDS (9, 10). Treatment with
multiple drug regimens has been shown to clear systemic
symptoms, reduce bacteremia, and improve survival (3, 10,
11). With more effective antiviral therapy for human immu-
nodeficiency virus infection and with prolonged survival, the
number of cases of disseminated MAC is likely to increase
substantially, and its relative contribution to AIDS mortality
is likely to increase concomitantly. As a result of these
developments, there will be an increased demand for diag-
nostic testing for MAC in both referral and community
hospitals.
Disseminated M. avium is confirmed when the organism
can be cultured from blood, bone marrow, or multiple
tissues. The most sensitive method for the detection of
mycobacteremia is the lysis-centrifugation blood culture
system (Isolator, Wampole Laboratories, Cranbury, N.J.)
(13). Lysis of leukocytes with saponin releases intracellular
mycobacteria and produces colony counts 1.9 to 5.2 times
higher than in unlysed blood (15). Pretreatment Isolator
cultures demonstrate 102 to 104 CFU/ml of blood (15).
Because the Isolator system requires special centrifuga-
tion and handling procedures and because smaller laborato-
ries may not be equipped to isolate and identify mycobac-
teria, there is need for a method to refer patient samples for
processing. Shipment of Isolator tubes to distant laborato-
ries has not been a consideration, because available data
have shown a delay in the time needed to recover bacteria
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when Isolator tubes are held for more than 8 h before
processing (2, 6). In one clinical study, delays of >9 h in
processing Isolator tubes was associated with a fivefold
reduction in the number of cultures positive for MAC (14).
However, environmental studies of MAC have shown that
organisms are viable for up to 30 days in natural water
samples (5), and MAC is known to grow on detergents such
as saponin (4).
The present study was conducted to determine whether
prolonged storage of MAC-infected blood in Isolator tubes
before processing would lead to quantitative reductions in
recovery rates of MAC or delays in recovery of MAC.
MATERIALS AND METHODS
Preparation of blood for simulated blood cultures. Four
units of whole blood anticoagulated with CPD (sodium
citrate, dextrose, sodium phosphate solution) were obtained
from healthy volunteers, stored for 1 day to 1 week at 4°C,
and then used. Before each experiment, blood was pooled,
mixed well, and divided into sterile beakers for further use.
M. avium-M. intracellulare strains and culture conditions.
Isolator blood cultures were performed on patients with
AIDS, plated on Middlebrook 7H10 agar, and incubated at
35°C in 5% CO2 (12). The organism used in experiments A
and B was initially recovered after 18 days of incubation.
Organisms were identified as M. avium-M. intracellulare
complex (Mayo Medical Laboratories, Rochester, Minn.) by
gas liquid chromatography (MIDI Microbial Identification
System, Newark, Del.). Serotyping was performed by Anna
Tsang, National Jewish Center for Immunology and Respi-
ratory Medicine (Denver, Colo.), by both enzyme-linked
immunosorbent assay (16) and thin-layer chromatography
(1). Isolates were saved for the present study by transferring
them to Middlebrook 7H10 agar at 35°C in 5% CO2. To
prepare inocula, a loopful of this growth was inoculated into
Middlebrook 7H9 broth, which was then transferred by
using a 1% inoculum at 5- to 15-day intervals at 35°C.
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TABLE 1. Experiment A: M. avium-M. intracellulare (serovar 6)
recovered from Isolator tubes inoculated in vitro and
held at room temperature before processing
Isolator CFU/ml at hold time of:
tube
no. O h 4 h 8 h 16 h 24 h 48 h 72 h 7 days
1 710 440 590 650 790 840 810 800
2 470 580 570 650 700 760 780 880
3 630 680 610 660 730 720 760 850
4 520 580 530 650 700 780 780 940
5 500 460 650 590 670 770 750 880
Mean 566 548 590 640 718 774 776 870
Preparation of inocula for simulated blood cultures. Inocula
were prepared by obtaining a log-phase broth (Middlebrook
7H9 plus 0.5% Tween) culture (5 days of growth) of M.
avium-M. intracellulare and adjusting it to a 1.0 McFarland
standard (11). This is referred to as the initial suspension.
Dilution of inocula. Experiments A and B were as follows.
Serial 1:10 dilutions of an initial suspension of M. avium-M.
intracellulare (serovar 6) were made in the broth to yield
suspensions of approximately 104 and 105 CFU/ml. Prelimi-
nary plating experiments were conducted to predict the
approximate number of CFU per milliliter in these initial
experiments. One milliliter of each M. avium-M. intracellu-
lare broth suspension was added to 100 ml of continuously
stirred pooled blood to yield a final concentration of approx-
imately 102 CFU/ml (experiment A) or 103 CFU/ml (experi-
ment B). The contents of each beaker were then continu-
ously stirred with a magnetic stir bar.
Experiment C was as follows. Serial dilutions of an initial
suspension of M. avium-M. intracellulare (serovar 8) were
made to yield concentrations of approximately 101, 102, 103,
and 104 CFU/ml. Two milliliters of the 101, 102, and 103
concentrations were added to 200-ml aliquots of blood to
yield final concentrations of 10-1, 100, and 101 CFU/ml.
Four milliliters of the 104 broth was added to 400 ml of blood
to yield a final concentration of 102 CFU/ml.
Patient Isolator blood culture. Blood from a 37-year-old
man with AIDS who was being treated with rifampin,
clofazimine, and ethambutol for known disseminated M.
avium-M. intracellulare (serovar 6) infection was drawn into
two Isolator tubes. One tube was processed immediately as
outlined below and the second tube was held at room
temperature for 7 days before being processed.
Inoculation and processing of Isolator tubes. For the simu-
lated cultures (experiments A, B, and C), sterile needles and
syringes were used to fill Isolator tubes with 10 ml each of
blood-broth suspension (after cleaning the stopper with
alcohol). All Isolator tubes (experiments A, B, C, and D)
were inverted several times and allowed to stand at room
temperature for 30 min (time 0) and for the subsequent hold
times. At time 0 and at each of the subsequent room
temperature hold times (4 h, 8 h, 16 h, 24 h, 48 h, 72 h, 7
days, 21 days, 28 days, and 56 days), Isolator tubes of each
M. avium-M. intracellulare concentration were centrifuged
for 30 min at 3,000 x g, the supernatant was withdrawn, and
the sediment was removed for culture according to the
manufacturer's instructions (Wampole Laboratories). The
entire sediment from each tube (approximately 1.5 ml) was
inoculated onto 5 Middlebrook 7H10 agar plates (approxi-
mately 0.3 ml per plate) and incubated at 35°C in 5% CO2. In
experiments A and B, the numbers of CFU were recorded
after 10, 18, and 40 days of incubation. In experiment C, the
number of CFU was recorded once after 5 to 10 weeks of
incubation. In experiment D, the number of CFU was
recorded once after 4 to 5 weeks of incubation.
RESULTS
Experiment A (inoculum, 102 CFU/ml). Delays in process-
ing of up to 1 week did not reduce the number of M.
avium-M. intracellulare CFU/ml recovered (Table 1). For
tubes held 24 h or more, there was actually an increase in
CFU compared with those processed immediately (time 0),
with maximum CFU per milliliter recorded for tubes pro-
cessed after a 7-day hold time. For tubes held 7 days before
processing, the numbers of CFU increased 54% (from 566 to
870 CFU/ml) compared with those of tubes processed im-
mediately (time 0).
Visible growth of individual colonies was apparent on all
plates (including those processed immediately and those
processed at 7 days) after incubation at 35°C for only 10
days, but colony counts were not maximal until 18 days of
incubation. Increasing hold times led to no differences in the
time to the first appearance of visible colonies. The numbers
of CFU recorded were 24 to 79% higher at 18 days of
incubation than at 10 days of incubation.
Experiment B (inoculum, 103 CFU/ml). More than 2,000
CFU/ml were recovered at all processing intervals (4 h to 7
days). Because growth on these plates was confluent, it was
not possible to ascertain small differences in recovery rates
after various processing times.
Experiment C (inocula, 10-1 to 102 CFU/ml). Delays in
processing of up to 1 week did not reduce recovery rates or
the time needed for visible growth even at an inoculum of
10-1 CFU/ml (Table 2). As in experiment A, the numbers of
CFU per milliliter were higher in tubes held 7 days at room
temperature than in tubes processed immediately. At the 102
TABLE 2. Experiment C: M. avium-M. intracellulare (serovar 8) recovered from Isolator tubes inoculated at various concentrations in
vitro and held at room temperature before processinga
CFU/ml (± SEM) at hold time of:
Inoculum
O h 8 h 24 h 7 days 21 days 28 days 56 days
10-1 0.6b (0.3) 0.7 (0.1) 0.6 (0.1) 1.0 (0.3) NDC ND ND
100 4.6 (0.6) 4.6b(0.2) 6.3 (0.1) 7.2 (0.5) ND ND ND
101 45.0 (1.0) 45.9 (1.5) 54.9 (1.2) 67.8b (2.1) ND ND ND
102 334 (31.8) 414 (10.1) 416 (17.8) 461 (25.3) 495 (59.4) 468 (35.5) 31.4 (8.54)
a Five tubes were inoculated and processed for each mean number of CFU per milliliter shown.
b Mean number of CFU per milliliter for four inoculated Isolator tubes (overgrowth of contaminant in fifth tube).
c ND, Not done.
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FIG. 1. Experiment C. Mean number of M. avium-M. intracel-
lulare CFU per milliliter (t 2 standard errors of the mean) recovered
from Isolator tubes inoculated with 102 CFU/ml in vitro and held at
room temperature before processing.
CFU/ml inoculum, M. avium-M. intracellulare was still
recovered when the Isolator tubes were processed after
being held for 8 weeks at room temperature; the numbers of
CFU per milliliter began to fall when processing was delayed
longer than 4 weeks (Fig. 1).
Experiment D (patient blood culture). The Isolator tube
taken directly from a patient with AIDS and processed
immediately grew to a concentration of 11 CFU/ml, and the
tube processed after being held for 7 days grew to a
concentration of 14 CFU/ml.
DISCUSSION
The present study demonstrates that MAC survives in
Isolator tubes for at least a week at concentrations encoun-
tered in disseminated human infection and suggests that
Isolator tubes may be shipped from one laboratory to
another at room temperature without loss of viability during
this interval. At an inoculum of 102 CFU/ml, organisms
survive as long as 8 weeks in the Isolator system before
being cultured on Middlebrook 7H10 agar. Since the num-
bers of CFU per milliliter were actually shown to increase
with hold times of up to 4 weeks, the Isolator system serves
as a suitable transport medium for MAC. Because the
numbers of CFU per milliliter begin to increase after hold
times of .8 h, Isolator blood cultures should be processed
within 8 h for quantitative bacteremia studies (e.g., drug
treatment studies). The present study also shows that delays
in processing of up to 1 week do not cause a delay in the time
required to detect visible colonies after plating on agar.
Previous studies on the delayed processing of Isolator
tubes either have not examined mycobacteria specifically or
have used a design different from that of the present study.
The studies of Hamilton et al. (6) and Cashman et al. (2)
showed that rapidly growing bacteria were viable in the
Isolator system after hold times of 8 to 24 h but that delayed
processing led to an increase in the time needed to recover
certain species (e.g., streptococci and members of the family
Enterobacteriaceae) and decreased quantitative recovery
rates for certain species (Streptococcus pneumoniae, Hae-
mophilus influenzae). Only one mycobacterial strain (identi-
fied only as atypical mycobacterium) was studied. Another
study compared the recovery of bacteria and fungi from
5,125 Isolator blood cultures held either less than 9 h or
between 9 and 20 h before being processed (14). M.
avium-M. intracellulare was recovered from 34 cultures, and
most of these were in the <9-h group. However, different
processing times were not applied to the same patient
samples. Rather, recovery of M. avium-M. intracellulare
was compared for patients whose blood was processed the
same day versus patients whose blood was drawn after 4:00
p.m. and processed the next day. With this study design, the
recovery rates may have reflected lower M. avium-M. intra-
cellulare infection rates among the patients whose blood was
cultured in the evening or night.
The principal finding of the present study, that M.
avium-M. intracellulare survives for long periods in the
Isolator system, is in accord with the known ability of the
organism to survive for prolonged periods in natural waters
(5) and the ability of detergents such as saponin to serve as
a growth medium for the organism (4).
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